These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 19956877)

  • 1. Calpain-mediated androgen receptor breakdown in apoptotic prostate cancer cells.
    Yang H; Murthy S; Sarkar FH; Sheng S; Reddy GP; Dou QP
    J Cell Physiol; 2008 Dec; 217(3):569-76. PubMed ID: 18726991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etoposide sensitivity of human prostatic cancer cell lines PC-3, DU 145 and LNCaP.
    Salido M; Larrán J; López A; Vilches J; Aparicio J
    Histol Histopathol; 1999 Jan; 14(1):125-34. PubMed ID: 9987657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Repression of VCaP Xenografts by a Pyrrole-Imidazole Polyamide.
    Hargrove AE; Martinez TF; Hare AA; Kurmis AA; Phillips JW; Sud S; Pienta KJ; Dervan PB
    PLoS One; 2015; 10(11):e0143161. PubMed ID: 26571387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cells.
    Lin HP; Lin CY; Hsiao PH; Wang HD; Jiang SS; Hsu JM; Jim WT; Chen M; Kung HJ; Chuu CP
    PLoS One; 2013; 8(12):e82625. PubMed ID: 24349321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High throughput screening of natural products for anti-mitotic effects in MDA-MB-231 human breast carcinoma cells.
    Mazzio E; Badisa R; Mack N; Deiab S; Soliman KF
    Phytother Res; 2014 Jun; 28(6):856-67. PubMed ID: 24105850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer.
    Reddy GP; Barrack ER; Dou QP; Menon M; Pelley R; Sarkar FH; Sheng S
    J Cell Biochem; 2006 Aug; 98(6):1408-23. PubMed ID: 16619263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Camptothecin disrupts androgen receptor signaling and suppresses prostate cancer cell growth.
    Liu S; Yuan Y; Okumura Y; Shinkai N; Yamauchi H
    Biochem Biophys Res Commun; 2010 Apr; 394(2):297-302. PubMed ID: 20206136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hinokitiol, a metal chelator derived from natural plants, suppresses cell growth and disrupts androgen receptor signaling in prostate carcinoma cell lines.
    Liu S; Yamauchi H
    Biochem Biophys Res Commun; 2006 Dec; 351(1):26-32. PubMed ID: 17055455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
    Chiu FL; Lin JK
    Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
    Jackson KM; Frazier MC; Harris WB
    Anticancer Res; 2007; 27(3B):1483-8. PubMed ID: 17595765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines.
    Nakauchi H; Matsuda K; Ochiai I; Kawauchi A; Mizutani Y; Miki T; Kawata M
    J Histochem Cytochem; 2007 Jun; 55(6):535-44. PubMed ID: 17312014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etoposide induces growth arrest and disrupts androgen receptor signaling in prostate cancer cells.
    Liu S; Yamauchi H
    Oncol Rep; 2010 Jan; 23(1):165-70. PubMed ID: 19956877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
    Wu JD; Haugk K; Woodke L; Nelson P; Coleman I; Plymate SR
    J Cell Biochem; 2006 Oct; 99(2):392-401. PubMed ID: 16639715
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.